Herpes vaccine to be tested in humans after best result yet in animals, finds a new study on herpes simplex 2 virus (HSV2). An experimental vaccine prevented genital lesions in all mice and guinea pigs tested. In 98% of mice and 80% of guinea pigs it also prevented the low-level “hidden” infections.